Making incisionless surgery a reality
Harmonic Medical is empowering clinicians to deliver
revolutionary treatment for uterine fibroids.
Approximately 80% of all women will develop uterine fibroids by age fifty. 20% of these women have symptoms severe enough to require treatment.
Hysterectomy is the most common surgical treatment for symptomatic uterine fibroids. It is a major surgery that involves the removal of the uterus.
Harmonic Medical is developing a focused ultrasound system that will allow women to be treated for uterine fibroids without the complications and long recovery times of hysterectomy. Harmonic Medical offers a fertility sparing, outpatient, incision-less, treatment for uterine fibroids.
Who We Are
Harmonic Medical’s team is developing the next generation of completely non-invasive surgery through the use of focused ultrasound.
We have solved the major problems that have limited widespread adoption of this revolutionary technology. Providing a solution that is: fast; suitable for a broad range of patients; and designed for the treating physician, without cumbersome and costly infrastructure like MRIs.
We are directing this revolutionary technology towards improving Women’s Health.
Innovative technology for non-invasive treatment
New Technology is changing lives
Disease treatment and management that previously required invasive complex surgical procedures with long recovery times can now be done:
Non-invasively – Without ever making an incision and with minimal-to-no recovery time
In an outpatient setting – With no hospital stay involved in the recovery
Thanks to FOCUSED ULTRASOUND
A technology that delivers ultrasound energy to a specific point inside the body in a method that is analogous to a magnifying glass focusing light on a point. This allows precise ablation of target tissues deep in the body.
Harmonic Medical’s Focused Ultrasound
Only Fully Steerable Array
Harmonic Medical has the world’s only fully steerable transducer phased array. This allows the focal spot to be moved anywhere in real time.
Compared to other focused ultrasound technologies, the Harmonic platform has unparalleled:
- Speed – High patient throughput
- Size and depth of treatment area – Large treatable population
Direct Measure of Tissue Coagulation
The Harmonic Medical platform monitors the effect of treatment on targeted tissue in real time using Local Harmonic Motion (LHM). By combining standard diagnostic ultrasound with focused ultrasound, we detect changes in tissue stiffness during treatment. This provides a safe and low-cost method of monitoring treatment.
BEYOND UTERINE FIBROIDS
Harmonic Medical’s technology is being investigated for treating the following broad range of cancer treatments:
- Bone Metastases
- Metastic Liver Cancer
- Hepatocellular Carcinoma
- Thyroid Cancer
- Pancreatic Cancer
- Kidney Cancer
Chief Executive Officer
15 years of executive experience in high technology company formation and growth. As a member of the Software Certification Consortium, he has first-hand knowledge of safety critical systems and the regulatory requirements for commercialization of medical devices and experience leading multi-million dollar projects.
VP Business Development
Broad background in the creation and business development of numerous companies in the Medical Imaging and Device space. He has been instrumental in attracting financing for early stage companies and research funding for emerging technologies.
Chief Financial Officer
20 years of professional experience as a CFO, VP Operations, Treasurer and Corporate Controller for Public (NASDAQ and TSE) and private companies. Experienced with firms in growth situations, where hands on knowledge of capital markets, cash management, and implementation of internal controls is essential.
Harmonic Medical is empowering clinicians to deliver Focused Ultrasound treatment to patients.
By delivering the ideal treatment that is:
- Rapid recovery times
- Low risk of complications
- No risk of infection